There are two possible mechanisms toexplain the initial improvement of hepatitis in our case: the PPARγ ligand may have directly suppressed theabnormal cell growth, or the PPARγ ligand may have indirectly suppressed tumor growth after the ligandimproved hepatitis and/or diabetes. Here, PPARG is linked to hepatitis A virus infection.